Dr Reddy's Lab launches Omeprazole in the US market

Published On 2018-12-15 03:30 GMT   |   Update On 2018-12-15 03:30 GMT

New Delhi: Dr Reddy's Laboratories recently said it has launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market.


"Dr Reddy's Laboratories has launched Omeprazole delayed-release tablets in the strength of 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec tablets, in the US," the company said in a BSE filing.






Quoting IRI data, Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around USD 492 million for the most recent twelve months ending in October 2018.


Read Also: Dr Reddy’s Laboratories recalls 35,000 tubes of skin infection cream from US

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News